Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-23T14:17:30.388Z Has data issue: false hasContentIssue false

Physician Preferences for Botulinum Toxin Injections in Anticoagulated Patients with Spasticity – CORRIGENDUM

Published online by Cambridge University Press:  13 May 2016

Rights & Permissions [Opens in a new window]

Abstract

Type
Brief Communications
Copyright
Copyright © The Canadian Journal of Neurological Sciences Inc. 2016 

doi:http://dx.doi.org/10.1017/cjn.2015.397

“Physician Preferences for Botulinum Toxin Injections in Anticoagulated Patients with Spasticity” by Kassam et al. was published with discrepancies in the numbers reported in Figures 1 and 2, and an error in the results.

Figure 1 Time of INR measurement before BoNTA injection*No description - 15%; <7 days - 7%

Figure 2 Comfort INR range for BoNTA injection*No answer - 8%; INR (2-3) - 1.4%; INR <3.5 - 1.4%; INR <3 - 3%

The second paragraph of the Results section should read: “Fifty-nine percent of the INR values were obtained by sending blood to the laboratory, with 44% of providers using INR values between 2 and 7 days before injection (Figure 1).” [Correction in bold.]

Corrected versions of Figures 1 and 2 are reproduced below. The authors regret the error.

References

1. Kassam, A, Phadke, CP, Ismail, F, Boulias, C. Physician Preferences for Botulinum Toxin Injections in Anticoagulated Patients with Spasticity. Can J Neurol Sci. 2016. doi:http://dx.doi.org/10.1017/cjn.2015.397.Google ScholarPubMed
Figure 0

Figure 1 Time of INR measurement before BoNTA injection*No description - 15%; <7 days - 7%

Figure 1

Figure 2 Comfort INR range for BoNTA injection*No answer - 8%; INR (2-3) - 1.4%; INR <3.5 - 1.4%; INR <3 - 3%